National

Indian Immunologicals launches classical swine fever vaccine for pigs

Our Bureau Hyderabad | Updated on May 28, 2020

Veterinary and human vaccines maker, Indian Immunologicals Limited (IIL), has launched the Classical Swine Fever (CSF) vaccine under the brand name ‘Raksha Class’.

The unique cell culture technology-based vaccine has been developed in collaboration with the Indian Veterinary Research Institute (IVRI), Bareilly.

According to K Anand Kumar, Managing Director, IIL CSF is one of the major diseases of pigs in India and causes a loss of about ₹400 crore per annum in India. The disease has led to a decrease of pig population in the country.

“With the launch of Raksha Class, we can ensure that the pig population in India can be increased and hence, the growers will be immensely benefited economically,’’ he said in a release.

The CSF is a highly contagious viral disease of pigs caused by an RNA virus. This disease has a high fatality rate and therefore, pig growers face serious economic problems with the loss of the herd.

The current requirement is about 22 million doses and the supply is less than a million doses.

The current vaccines manufactured by a few state biologicals depend on the rabbits for vaccine production, where consistency in yields, virus titres, safety and efficacy might not be achieved to the desired levels. IIL’s manufacturing facilities can make several million doses of the vaccine.

Published on May 28, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like